| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
25,590,000 |
| Market
Cap: |
598.29(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.24 - $20.92 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 9.4 |
| Insider 6 Months : 10.9 |
| Insider 3/6 Months : 20.7 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CM Life Sciences is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
40,900 |
155,642 |
175,642 |
129,032,254 |
| Total Buy Value |
$357,652 |
$519,020 |
$588,932 |
$45,881,412 |
| Total People Bought |
1 |
2 |
3 |
8 |
| Total Buy Transactions |
2 |
4 |
7 |
12 |
| Total Shares Sold |
25,996 |
932,119 |
981,723 |
8,139,549 |
| Total Sell Value |
$271,904 |
$1,457,426 |
$1,733,341 |
$4,641,291 |
| Total People Sold |
3 |
4 |
6 |
12 |
| Total Sell Transactions |
9 |
19 |
44 |
77 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ro Isaac |
Former CFO |
• – – |
2022-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,396 |
209,182 |
|
- |
|
| Prentice Anthony |
Former Chief Product Officer |
– – – |
2022-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,576 |
14,436 |
|
- |
|
| Clark Daniel Emmett |
Former Secretary and GC |
– – – |
2022-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,005 |
313,552 |
|
- |
|
| White Karen Ann |
Chief People Officer |
• – – |
2022-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,276 |
12,782 |
|
- |
|
| Miao Richard |
Former Interim CFO |
– – – |
2022-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,139 |
25,482 |
|
- |
|
| Saad Kareem |
Chief Transformation Officer |
• – – |
2022-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,005 |
73,294 |
|
- |
|
| Miao Richard |
Interim CFOOfficer |
• – – |
2022-06-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,343 |
|
-34% |
|
| Schadt Eric |
President & Chief R&D Officer |
• • – |
2022-05-20 |
4 |
B |
$1.92 |
$192,480 |
D/D |
100,000 |
243,380 |
2.81 |
-55% |
|
| Assad Shawn |
Chief Accounting Officer |
• – – |
2022-05-11 |
4 |
S |
$1.75 |
$5,475 |
D/D |
(3,128) |
32,107 |
|
41% |
|
| Ro Isaac |
Chief Financial Officer |
• – – |
2022-05-10 |
4 |
S |
$2.46 |
$48,007 |
D/D |
(19,515) |
201,786 |
|
44% |
|
| Assad Shawn |
Chief Accounting Officer |
• – – |
2022-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,457 |
35,235 |
|
- |
|
| Ro Isaac |
Chief Financial Officer |
• – – |
2022-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,500 |
221,301 |
|
- |
|
| Ruch Joshua |
Director |
– • – |
2022-04-29 |
4 |
A |
$4.00 |
$8,500,000 |
I/I |
2,125,000 |
162,372 |
|
- |
|
| Opko Health, Inc. |
10% Owner |
– – • |
2022-04-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
80,000,000 |
|
-49% |
|
| Mount Sinai Health System, Inc. |
10% Owner |
– – • |
2022-04-29 |
4 |
B |
$4.00 |
$25,000,000 |
D/D |
6,250,000 |
94,605,473 |
2.45 |
-49% |
|
| Schwarzman Stephen A |
10% Owner |
– – • |
2022-04-29 |
4 |
B |
$4.00 |
$10,000,000 |
I/I |
2,500,000 |
162,309 |
1.5 |
-49% |
|
| Casdin Eli |
Director |
– • – |
2022-04-29 |
4 |
B |
$4.00 |
$45,750,000 |
I/I |
11,437,500 |
16,437,500 |
2.1 |
-49% |
|
| Meister Keith |
Director |
– • – |
2022-04-29 |
4 |
B |
$4.00 |
$45,750,000 |
I/I |
11,437,500 |
26,931,250 |
2.1 |
-49% |
|
| Blackstone Tactical Opportunities Fund - Fd L.p. |
10% Owner |
– – • |
2022-04-29 |
4 |
B |
$4.00 |
$10,000,000 |
I/I |
2,500,000 |
162,309 |
1.5 |
-49% |
|
| Clark Daniel Emmett |
Secretary and General Counsel |
• – – |
2022-04-28 |
4 |
S |
$2.18 |
$2,643 |
D/D |
(1,212) |
309,547 |
|
51% |
|
| White Karen Ann |
Chief People Officer |
• – – |
2022-04-28 |
4 |
S |
$2.18 |
$3,118 |
D/D |
(1,430) |
9,506 |
|
51% |
|
| Prentice Anthony |
Chief Product Officer |
• – – |
2022-04-28 |
4 |
S |
$2.18 |
$3,688 |
D/D |
(1,691) |
9,860 |
|
51% |
|
| Schadt Eric |
President & Chief R&D Officer |
• • – |
2022-04-28 |
4 |
S |
$2.18 |
$78,274 |
D/D |
(35,899) |
143,380 |
|
51% |
|
| Leproust Emily M. |
Director |
– • – |
2022-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,836 |
37,836 |
|
- |
|
| Pellini Michael J |
Director |
– • – |
2022-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,836 |
12,836 |
|
- |
|
271 Records found
|
|
Page 8 of 11 |
|
|
2.63 (12.67%) 
